Illustrative image – not actual. Dr Reddy's Laboratories has signed an MoU with Tokyo based Fujifilm Corporation to form a JV in Japan.
The proposed JV will develop, manufacture and promote generic drugs in Japan. Dr Reddy's and Fujifilm will have 49 per cent and 51 per cent stake in the company, respectively. A definitive agreement will be signed during the course of the calendar year. The JV plans to launch its first products in Japan by 2014. It will also develop products to suit specific requirements of the Japanese market in the generics space.
The proposed JV will develop, manufacture and promote generic drugs in Japan. Dr Reddy's and Fujifilm will have 49 per cent and 51 per cent stake in the company, respectively. A definitive agreement will be signed during the course of the calendar year. The JV plans to launch its first products in Japan by 2014. It will also develop products to suit specific requirements of the Japanese market in the generics space.
